Cost burden and net monetary benefit loss of neonatal hypoglycaemia

BACKGROUND: Neonatal hypoglycaemia is a common but treatable metabolic disorder that affects newborn infants and which, if not identified and treated adequately, may result in neurological sequelae that persist for the lifetime of the patient. The long-term financial and quality-of-life burden of ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Glasgow, Matthew J., Edlin, Richard, Harding, Jane E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863541/
https://www.ncbi.nlm.nih.gov/pubmed/33546675
http://dx.doi.org/10.1186/s12913-021-06098-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863541/
https://www.ncbi.nlm.nih.gov/pubmed/33546675
http://dx.doi.org/10.1186/s12913-021-06098-9

Ejemplares similares